Follow the Money (4.23.2026) Dr. Jack Cush follows the money and all the news that fits the Rheumatology Gab for this past week. https://t.co/nEWINTOw6L https://t.co/a4oZxqwYhv

True or False: The DESIR axSpA cohort study found a significant association between NSAID use and incident hypertension over 10 years. See if you got it right in the latest RheumIQ quiz at https://t.co/N5rfozh757. https://t.co/tkj0na3bkh

The impact oif obesity on the immune system. Through methylation, obesity imprints memory to CD4+ (helper) T cells, which can last for many years, and promotes immune system dysregulation and inflammation. @emboreports https://t.co/j2tASpZlE0 https://t.co/5CgUrsFZru

APR: Difficult to Treat RA Companion slide deck for the Advanced Practice Rheum: Difficult to Treat Rheumatoid Arthritis video, featuring Dr. Jack Cush. https://t.co/GXnTicNTL6 https://t.co/ojOsMZ4sA7

Managing PsA disease activity across GRAPPA domains with a JAKi: how could a domain-based framework inform care for your patients with PsA? Explore efficacy & safety data. Hear expert insights. Sponsored by AbbVie Medical Affairs + Health Impact. https://t.co/njK6umFoSb https://t.co/kfczPzAXdw

Knee pain: JAMA review - 5% PCP visits knee pain - Knee OA ~654 million worldwide - Patellofemoral pain: <40 yrs & physically active; pain on squat - Meniscal tears in 12% adults (McMurray 61% sensitive; 84% specific; Joint line tender 83% sensitive; 83% specific) https://t.co/M7om9DN7Zu

Are uveitis and psoriasis independently associated with greater spinal radiographic progression in ankylosing spondylitis? Test your knowledge in the latest RheumIQ quiz at https://t.co/N5rfozh757 https://t.co/PjY1iuLv0X

Prospective study of 305 Consecutive newly diagnosed axSpA pts (55% male; Dx delay 6 yrs; 75% B27+). 56% w/ r-axSpA more male w/ hi CRP. nr-axSpA had more inflam LBP, +FHx SpA. SpA Dx made without sacroiliitis in 12%; only 2/38 later developed sacroiliitis https://t.co/xPlGwZ7Kjk https://t.co/E7dNVar6dZ

Danish registry study of truncal (2,260) vs superselective (3,810) vagotomy (1977-95) vs general popul. (10:1). Truncal incr. RA risk (aHR 2.62), but selective did not (aHR 1.05. Neither had effect on OA risk https://t.co/dqejtN9TwY https://t.co/R0OJZTxd5T 

Anifrolumab (Saphnelo) approved in the US for subcutaneous self-administration as a new autoinjector for the treatment of systemic lupus erythematosus based on SC-TULIP study. Presumeably, all prior CRL issues resolved to FDA satisfaction... https://t.co/ZtZmJLcGYa https://t.co/HnEzSgItXa 

Sun Pharma buys out Organon w/ $11.75 billion buyout. Both generated $6.2 billion in 2025 sales. Organon spun off from ‌Merck in 2021, specializes in women’s health and is top 7 in biosimilars. Sun is into dermatology, ophthalmology and oncology-dermatology. https://t.co/zb4hucTqCJ

Presented at AACE Annual Meeting, FREEDOM Real-World Study looked atypical femoral Fxs & found a low AFF risk - 24 AFFs w/ denosumab (0.89/1KPY) vs 397 AFFs w/ bisphosphonates (0.82/1KPY) but no active comparators & excluded pts w/ comorbidities. https://t.co/vRwkfHSXxh https://t.co/xzgC0D5ZTu